CJC-1295 No DAC
CJC-1295 No DAC is a synthetic analog of growth hormone-releasing hormone (GHRH 1-29) that is designed to be more stable but still biologically active. It should be noted that this drug differs from CJC-1295 DAC in terms of a much shorter duration of action and is a perfect choice for experiments with pulsatile secretion of […]
CJC-1295 No DAC is a synthetic analog of growth hormone-releasing hormone (GHRH 1-29) that is designed to be more stable but still biologically active. It should be noted that this drug differs from CJC-1295 DAC in terms of a much shorter duration of action and is a perfect choice for experiments with pulsatile secretion of growth hormone and receptor activation.
Scientists apply CJC-1295 No DAC in laboratory settings in order to study GHRH receptor activation, growth hormone release, IGF-1 signaling, pituitary physiology, endocrinology, protein synthesis, muscle metabolism, recovery processes, and age endocrine studies. The studies of the effect of short-acting analogs of GHRH on physiological hormone pulses have been carried out in experimental settings.
In contrast to therapeutic drugs, the product CJC-1295 No DAC offered by PeptidesX is meant solely for laboratory studies and pre-clinical experiments. It has no approval for administration to people and animals. Each batch of the drug comes with a Certificate of Analysis that provides information on its identification and batch-related analysis. Before starting the experiment, scientists have to examine the Certificate of Analysis.
All the products of CJC-1295 No DAC offered by PeptidesX are strictly for research purposes only and are not for use in humans and animals.
Research Areas
- Growth hormone-releasing hormone (GHRH) receptors
- Growth hormone pulsatility experiments
- IGF-1 signal transduction pathway analysis
- Hormone control within the pituitary gland
- Endocrine system and neuroendocrine signal analysis
- Muscle protein synthesis and recovery pathways
- Healthy ageing and metabolism studies
- Growth hormone pulses and receptors
⚠ Research Use Only.
All products supplied by PeptidesX are intended strictly for in-vitro laboratory and scientific research. Not for human consumption, medical use, veterinary use, or therapeutic application. Researchers are responsible for compliance with all applicable regulations in their jurisdiction.
Identity & Purity
HPLC / MS-UPLC| Test | Specification | Result |
| Appearance | White lyophilised powder | ✓ Conforms |
| HPLC Purity | ≥ 98.0% | 99.% ✓ |
| MS Molecular Weight | Expected ± 0.5 Da | Confirmed ✓ |
| Amino Acid Analysis | Theoretical sequence | Confirmed ✓ |
| Water Content (KF) | ≤ 8.0% | 5.4% ✓ |
| Net Peptide Content | ≥ 85.0% | 90.8% ✓ |
Safety Testing
Endotoxin / Metals| Test | Specification | Result |
| Endotoxin (LAL) | ≤ 5 EU/mg | 0.9 EU/mg ✓ |
| Bioburden | ≤ 100 CFU/g | <10 CFU/g ✓ |
| Lead (Pb) | ≤ 10 ppm | <0.1 ppm ✓ |
| Arsenic (As) | ≤ 5 ppm | <0.1 ppm ✓ |
| Mercury (Hg) | ≤ 3 ppm | <0.1 ppm ✓ |
| Cadmium (Cd) | ≤ 5 ppm | <0.1 ppm ✓ |
Solubility: Water / Acetic acid. Mix gently by rolling — do not vortex.
Returns: Sealed, unopened vials may be returned within 14 days of receipt. Opened vials cannot be returned.
CJC-1295 No DAC is an analogue of growth hormone releasing hormone (GHRH) manufactured for laboratory study of growth hormone secretion and pituitary endocrine functions.
The term "No DAC" shows that the peptide does not have the Drug Affinity Complex (DAC). The absence of DAC makes the peptide have shorter time of effect making it ideal for research of pulsatile hormone release.
Yes. CJC-1295 No DAC can be bought at PeptidesX for laboratory research purpose in the United Kingdom. The peptide is delivered only for scientific studies and cannot be used for any other purposes such as human or veterinary usage.
Choose the suitable product of CJC-1295 No DAC from the catalogue on the PeptidesX site and make an online order. Supplies of this peptide are made according to research-use-only policy of the company.
All batches of peptides are tested individually and delivered together with a certificate of analysis for each batch. Scientists must confirm the purity, identity and analytical data of the product by reading the Certificate of Analysis.
Scientists study CJC-1295 No DAC in order to learn more about GHRH receptor activation, pulsatile release of growth hormone, IGF-1 signaling etc.
Most research revolves around the study of the pituitary gland, pulsatility of hormone secretion, growth hormone secretion, hormonal signalling, muscle metabolism, recovery mechanisms, aging, and regulation of growth factors using laboratory preclinical models
CJC-1295 No DAC is offered as a lyophilized research peptide for laboratory study. Information about the product specifications, its purity, and other batch details can be found on the appropriate product page.
The storage instructions for the product can be found on the product label and Certificate of Analysis. The product should be stored under laboratory conditions while avoiding exposure to heat, humidity, and constant temperature changes.
Preclinical research indicates stimulation of growth hormone secretion after the activation of the GHRH receptor. However, it comes from preclinical and animal experiments that cannot be taken as evidence of the effectiveness and safety of the product for humans.
Yes. Researchers conduct experiments on CJC-1295 No DAC when studying endocrine physiology, metabolic processes, IGF-1 signaling, muscle physiology, healthy aging, and hormone pulse dynamics.
No. CJC-1295 No DAC is an investigational research peptide and is not recognized by PeptidesX as a drug, dietary supplement, or treatment of any disease.
No. The PeptidesX CJC-1295 No DAC product is sold solely for research purposes. Results of experiments conducted in vitro and in vivo do not prove the safety, effectiveness, or applicability to humans.
There are UK shipping options available at checkout. Shipping methods and their costs are listed on the website prior to completing an order.
The PeptidesX CJC-1295 No DAC product is meant for universities, research labs, biotech firms, and scientists conducting valid research in the lab.